Skip to main content
Regeneron planning a coronavirus cocktail treatment

Regeneron Pharmaceuticals announced that it will pick the top two antibodies out of hundreds it has identified for the development of a cocktail treatment that may be used to potentially treat or prevent COVID-19, with the company planning to launch clinical trials by early summer.

Full Story: